Financials
Financial year 2025
PHARMAX from Liège, company number BE0461189963, closed financial year 2025 with a result of € 76,733 after tax. For that financial year PHARMAX recorded a gross margin of € 108,249 and equity of € 457,161. Compared with financial year 2024, the result moved from € 78,738 to € 76,733. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 457,161
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 76,733
▼ 3% vs 2024
Profit after tax over the fiscal year.
€ 361,161
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 79,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 13,688
▼ 38% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 39,538
▲ 36% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,675
▲ 66% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 109,811 | € 99,156 | € 111,299 | € 108,249 | ▼ 3% |
| Profit after taxes | € 70,288 | € 59,731 | € 78,738 | € 76,733 | ▼ 3% |
| Equity | € 418,960 | € 458,691 | € 459,428 | € 457,161 | |
| Total debts | € 115,025 | € 64,197 | € 115,455 | € 129,116 | ▲ 12% |
| Cash | € 312,250 | € 286,005 | € 358,509 | € 361,161 | ▲ 1% |
| Land & buildings | € 10,653 | € 8,428 | € 13,708 | € 10,939 | ▼ 20% |
| Retained profit | € 356,960 | € 396,691 | € 397,428 | € 395,161 | ▼ 1% |
| Dividend | € 23,000 | € 20,000 | € 78,000 | € 79,000 | ▲ 1% |
| Balance sheet total | € 533,985 | € 522,888 | € 574,884 | € 586,278 | ▲ 2% |
By gross margin, PHARMAX ranks 12th of 16 companies with main activity “Detailhandel in farmaceutische producten” in Liège that publish figures (fiscal year 2025).
Key figures of PHARMAX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about PHARMAX the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMAX?
What happened at PHARMAX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- MARIE BRAUN stepped down as director. NBB
- MATHILDE BRAUN stepped down as director. NBB
- CATHERINE HALKIN stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 76,733 (▼ 3% vs 2024). Source: NBB ↗
- MARIE BRAUN became a director. NBB
- MATHILDE BRAUN became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 70,288 profit in 2022 to € 76,733 profit in 2025.
Paid € 96,346 in corporate taxes since 2022.
Best year ever: 2024, with € 78,738 profit.
Paid out € 200,000 in dividends to the owners in total.
Management
Directors
According to the 2025 annual accounts
since 2023 · until 2029
MATHILDE BRAUN
Director
since 2023 · until 2029
CATHERINE HALKIN
Director
since 1997 · until 2029
Establishments
Establishment units
Physical locations of this company
Rue de Visé 26
4020 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Liège
Same main activity (Detailhandel in farmaceutische producten), 15 active companies in Liège, largest first.
€ 799,524 gross margin · 2025
€ 492,145 gross margin · 2025
€ 403,154 gross margin · 2025
€ 371,790 gross margin · 2025
€ 215,216 gross margin · 2025
€ 206,901 gross margin · 2025
Details
- Company number
- 0461.189.963
- VAT number
- BE 0461.189.963
- Registered office
- Rue de Visé 26, 4020 Liège
- Names & denominations
- PHARMAX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 July 1997
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers